In breast cancer, COX-2 plays a significant role in inflammation and is a crucial target of non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin (ASP) and ibuprofen, that may be chemoprotective agents against breast cancer [30]. The gene discussed is PTGS2; the disease is breast carcinoma.